Financial Performance - The company's total revenue for the first half of 2025 was 235 million yuan, a decrease of 15.39% year-on-year [1] - The net profit attributable to shareholders was 16.92 million yuan, down 17.19% year-on-year [1] - The gross profit margin was 18.21%, a decrease of 3.72% year-on-year, while the net profit margin was 7.19%, down 2.19% year-on-year [1] - The company's accounts receivable increased by 33.79% year-on-year, reaching 293 million yuan [1][3] Cost and Expense Analysis - Total sales, management, and financial expenses amounted to 14.31 million yuan, accounting for 6.08% of revenue, a decrease of 11.69% year-on-year [1] - Sales expenses decreased by 22.57% due to reduced advertising and promotional costs [10] - Management expenses decreased by 28.97% as a result of lower listing-related costs [11] - Financial expenses increased by 150.35% due to an increase in structured deposits [12] Cash Flow and Assets - The company's cash and cash equivalents decreased by 53.62% due to last year's fundraising [3] - The net cash flow from operating activities was significantly negative at -0.72 yuan per share, a decrease of 316.37% year-on-year [1][12] - The company reported a 95.67% increase in contract liabilities due to an increase in prepayments related to contracts [7] Business Development and Strategy - The company is focusing on the development of its micro-special motors and components, as well as precision drug delivery devices [16] - It aims to deepen cooperation with existing strategic customers while actively exploring new clients [16][17] - The company is investing in R&D for core technologies in frameless motors, targeting high-end applications in robotics and medical devices [14] Market Position and Competitive Advantage - The company holds a strong market share in the micro-special motors segment, particularly among major home appliance manufacturers [17] - It has established long-term partnerships with domestic and international pharmaceutical companies in the precision drug delivery device sector [17][18] - The company emphasizes quality management and continuous innovation as key components of its competitive strategy [18]

Group 1: Company Overview and Business Segments - The company focuses on two main business segments: micro-special motors and precision drug delivery devices [3][4] - In the micro-special motors segment, the company is actively expanding its customer base while enhancing automation and intelligent production to reduce costs and improve quality [3] - The precision drug delivery device segment is deepening cooperation with existing strategic clients and exploring new clients, with several customized projects currently in testing and validation stages [3] Group 2: Research and Development Progress - The company has made significant breakthroughs in core technologies for frameless motors, including high torque density magnetic circuit design and high-precision servo control algorithms [2][3] - Continuous investment in R&D is aimed at achieving breakthroughs in the precision drug delivery device sector, leveraging the company's established expertise in micro-special motors [4][8] Group 3: Market Potential and Future Outlook - The future market demand for injection pens is expected to be substantial, particularly in the fields of diabetes and weight loss medications, with significant potential for domestic substitution [6][8] - The company aims to become a leading player in the domestic precision drug delivery device market, capitalizing on its early market entry and comprehensive product line [8] Group 4: Competitive Advantages - The company enjoys a strong customer resource advantage, with a stable market share in the air conditioning sector among major brands like Midea, Gree, and Haier [4] - A robust R&D team with extensive experience in product development and process innovation supports the company's competitive edge [4] - The company adheres to a core value of quality management, which has garnered positive feedback and multiple accolades from clients [4] Group 5: Mergers and Acquisitions Strategy - The company is focused on its core business while seeking quality targets for potential mergers and acquisitions, with plans to disclose any significant developments in accordance with legal regulations [5]

Group 1: Business Overview - The company has established long-term stable partnerships with major home appliance manufacturers such as Midea, Gree, Haier, Hisense, and Aux in the micro motor and components business [1] - The company is focusing on breakthrough core technologies for frameless motors in 2025, aiming to serve the robotics and high-end medical device sectors [1] - The precision drug delivery business is deepening cooperation with existing strategic clients, enhancing customer stickiness [2] Group 2: Market Expansion and Future Plans - In 2024, the company successfully entered the supply chains of well-known enterprises like Xiaomi, Carrier, and Sharp in the micro motor sector [2] - The company plans to accelerate automation and intelligent production transformation in micro motor manufacturing to reduce costs and enhance product competitiveness [2] - The precision drug delivery device business is expanding into new drug areas, including partnerships with major pharmaceutical companies [3] Group 3: Financial Performance - In Q1 2025, the company reported total revenue of ¥113,166,954.09, a year-on-year increase of 2.86% [4] - The net profit attributable to shareholders was ¥7,867,033.66, reflecting a 1.00% increase compared to the same period last year [4] Group 4: Competitive Advantages - The company holds a strong market share in the micro motor sector, particularly in the air conditioning segment, with stable partnerships with leading appliance manufacturers [4] - Continuous investment in R&D has led to breakthroughs in the precision drug delivery device sector [4] - The company emphasizes quality management, which has garnered positive feedback and multiple honors from clients [4]

Group 1: Company Strategy and Goals - The overall business goal is to strengthen precision motors and become a leader in the medical device industry, focusing on technology-driven innovation and market competitiveness [2][3]. Group 2: Market Expansion and Developments - In 2024, the company successfully entered the supply chains of well-known enterprises such as Xiaomi and Sharp, with plans to enhance market penetration and automation in precision motor production [3]. - The precision drug delivery device business generated revenue of 36.76 million yuan in 2024, a decrease of 36.17% year-on-year, primarily due to cyclical orders from clients [4]. Group 3: Financial Performance - In 2024, the company achieved an operating income of 483.41 million yuan, a year-on-year increase of 1.57%, while net profit attributable to shareholders decreased by 48.51% to 33.65 million yuan [8]. - For Q1 2025, operating income reached 113.17 million yuan, a 2.86% increase year-on-year, with net profit growing by 1.00% to 7.87 million yuan [8]. Group 4: Future Plans and R&D - Key plans for 2025 include business expansion, automation of production lines, and breakthroughs in core technologies for frameless motors and high-viscosity drug injection devices [4]. - The company allocated 18.84 million yuan for R&D in 2024, representing 3.90% of operating income, focusing on advanced motor technologies and drug delivery systems [10]. Group 5: Social Responsibility and Customer Relations - The company emphasizes shareholder protection, employee rights, and environmental sustainability, while maintaining strong relationships with major clients like Midea and Gree [5][7].

Core Viewpoint - The company has reported a stable growth in its main business segments, particularly in micro-special motors and precision drug delivery devices, with a focus on innovation and market expansion. Company Overview - The company's main business is the research, production, and sales of micro-special motors and application products, which accounted for 84.80% of its revenue during the reporting period [3][4]. - The precision drug delivery device business is identified as an important innovation direction for the company [3]. Financial Performance - The company achieved revenue of 409.94 million yuan from micro-special motors and components, representing a year-on-year growth of 7.13% [4]. - The precision drug delivery device business generated revenue of 36.76 million yuan, with a business model based on deep collaboration with pharmaceutical companies [7]. Innovation and Market Development - The company has developed innovative products such as a gearbox component that enhances motor drive efficiency and a new type of ultrasonic piezoelectric actuator motor [5]. - The company has successfully expanded its customer base, including notable clients like Xiaomi, and has made inroads into international markets with products entering the supply chains of companies like Carrier and Sharp [5][6]. Production Management - The company practices lean production principles, optimizing production processes and enhancing automation levels to ensure product reliability and consistency [6]. - Comprehensive upgrades and automation modifications to existing production lines have improved production efficiency and product quality [6]. Industry Position - The company has established itself as a significant player in both the micro-special motors and precision drug delivery device sectors, with a strong reputation and customer base [10]. - It serves major domestic appliance groups such as Midea, Gree, and Haier, and has expanded its market share by acquiring new clients [10]. Profit Distribution - The company plans to distribute a cash dividend of 3.5 yuan per 10 shares, totaling approximately 19.98 million yuan, based on its total share capital of 57.08 million shares [2][40].